Retrospective cohort study to characterise the blood pressure response to spironolactone in patients with apparent therapy-resistant hypertension using electronic medical record data

Retrospective cohort study to characterise the blood pressure response to spironolactone in patients with apparent therapy-resistant hypertension using electronic medical record data

Objective Identify blood pressure (BP) response to spironolactone in patients with apparent therapy-resistant hypertension (aTRH) using electronic medical records (EMRs) in order to estimate response in a real-world clinical setting.Design Developed an algorithm to determine BP and electrolyte respo...

Full description

Bibliographic Details
Main Authors:	Megan Shuey, Bradley Perkins, Hui Nian, Chang Yu, James M Luther, Nancy Brown
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2020-05-01
Series:	BMJ Open
Online Access:	https://bmjopen.bmj.com/content/10/5/e033100.full

Similar Items

Novel role of spironolactone in the therapy of resistant hypertension: Spironolactone and resistant hypertension
by: Dragojević-Simić Viktorija, et al.
Published: (2019-01-01)

PATHWAY-2: spironolactone for resistant hypertension
by: Dale, A, et al.
Published: (2016)

Association between Use of Spironolactone and Risk of Stroke in Hypertensive Patients: A Cohort Study
by: Xintian Cai, et al.
Published: (2022-12-01)

Role of spironolactone in patients with resistant hypertension: A narrative review
by: Geeta Sheth, et al.
Published: (2021-01-01)

Hypertensive mediated organ damage evolution in resistant hypertension patients after adding spironolactone
by: Isabel Galceran, et al.
Published: (2023-05-01)

Treatments and diets associated with resistant arterial hypertension and their influence on the efficacy of spironolactone
by: Nicolle Fabiola Quiñonez Quiñones, et al.
Published: (2024-05-01)

Efficacy and Safety of Spironolactone in the Treatment of Resistant Hypertension：a Meta-analysis
by: ZHANG Ping, ZOU Jing, GAO Cunzhou, WU Aiping, LI Rongshan
Published: (2022-03-01)

Association of spironolactone treatment and arterial stiffness and cardiovascular disease in hypertensive patients
by: Fanfang Zeng, et al.
Published: (2019-06-01)

The Effect of Spironolactone on Control of Pulmonary Hypertension in Patients with Obstructive Pulmonary Disease
by: Mohammad Emami, et al.
Published: (2019-01-01)

Diuretic Effect of Prosopis farcta in Comparison with Spironolactone and Hydrochlorothiazide in Hypertensive Rats
by: Zana M.Raoof, et al.
Published: (2020-06-01)

Spironolactone in pulmonary arterial hypertension: results of a cross-over study
by: Zeenat Safdar, et al.
Published: (2020-04-01)

Spironolactone for the treatment of acne in women, a retrospective study of 110 patients
by: J.W. Charny, BS, et al.
Published: (2017-06-01)

Effects of spironolactone in spontaneously hypertensive adult rats subjected to high salt intake
by: Marcelo Perim Baldo, et al.
Published: (2011-01-01)

Reversal of Spironolactone-Induced Gynecomastia:
by: Alex Carsel
Published: (2023-05-01)

Spironolactone mitigates, but does not reverse, the progression of renal fibrosis in a transgenic hypertensive rat
by: Catherine J. Leader, et al.
Published: (2020-05-01)

Effect of spironolactone use in pulmonary arterial hypertension – analysis from pivotal trial databases
by: Zeenat Safdar, et al.
Published: (2021-10-01)

Addition of spironolactone in patients with resistant hypertension: A meta-analysis of randomized controlled trials
by: Liping Liu, et al.
Published: (2017-04-01)

1.6 SPIRONOLACTONE REDUCES AORTIC STIFFNESS IN PEOPLE WITH A HYPERTENSIVE RESPONSE TO EXERCISE VIA THE BLOOD PRESSURE-DEPENDENT EFFECTS OF CANRENOATE
by: S.B. Nikolic, et al.
Published: (2012-11-01)

Imatinib and spironolactone suppress hepcidin expression
by: Katarzyna Mleczko-Sanecka, et al.
Published: (2017-07-01)

A systematic review and meta-analysis of effects of spironolactone on blood pressure, glucose, lipids, renal function, fibrosis and inflammation in patients with hypertension and diabetes
by: Mengyue Lin, et al.
Published: (2021-05-01)

Effectiveness of Spironolactone in Reducing Osteoporosis and Future Fracture Risk in Middle-Aged and Elderly Hypertensive Patients
by: Song S, et al.
Published: (2024-06-01)

Spironolactone Use and Improved Outcomes in Patients With Heart Failure With Preserved Ejection Fraction With Resistant Hypertension
by: Tetsuro Tsujimoto, et al.
Published: (2020-12-01)

Characteristics, management, and blood pressure control in patients with apparent resistant hypertension in the US
by: Eric M. Ammann, et al.
Published: (2023-02-01)

P88 Improvement in Functional Capacity with Spironolactone Masks the Treatment Effect on Exercise Blood Pressure
by: Myles Moore, et al.
Published: (2020-02-01)

P.009 THE EFFECT OF SPIRONOLACTONE ON PULSE WAVE CHARACTERISTICS IN HYPERTENSION: INFLUENCE OF THE ALDOSTERONE TO RENIN RATIO (ARR)
by: K.M.S. AlHashmi, et al.
Published: (2007-08-01)

Effectiveness and Safety of Spironolactone in the Treatment of IgA Nephropathy: A Retrospective Self-Controlled Study
by: Da Shang, et al.
Published: (2024-07-01)

Retrospective analysis of adverse events with spironolactone in females reported to the United States Food and Drug Administration
by: Yu Wang, BA, et al.
Published: (2020-09-01)

Spironolactone in hidradenitis suppurativa: a single-center
by: Rahul Masson, BS, et al.
Published: (2024-03-01)

Spironolactone-Induced Agranulocytosis: A Case Report
by: Shu-Hwa Hsiao, et al.
Published: (2003-11-01)

The Dose-Dependent Effects of Spironolactone on TGF-β1 Expression and the Vulnerability to Atrial Fibrillation in Spontaneously Hypertensive Rats
by: Mirong Tang, et al.
Published: (2021-01-01)

Efficacy of spironolactone in treating hidradenitis suppurativa in women of childbearing age: a single-center retrospective analysis
by: Suma V. Gangidi, BS, et al.
Published: (2024-10-01)

Spironolactone as an alternative way of treating acne in women - review
by: Magdalena Gajkiewicz, et al.
Published: (2024-08-01)

Effect of spironolactone on survival in patients undergoing maintenance hemodialysis.
by: Seok Hui Kang, et al.
Published: (2024-01-01)

Spironolactone 25 mg tablets prescription in Primary Care
by: Eliezer Alemán-Fernández
Published: (2023-10-01)

Effects of Spironolactone on Proteinuria of Patients with Type 2 Diabetes
by: Mohamad Karami Horestani, et al.
Published: (2012-10-01)

Hypokalemia results of treatment for patients in peritoneal dialysis with spironolactone
by: César A. Restrepo Valencia, et al.
Published: (2016-01-01)

Spironolactone in chronic hemodialysis patients improves cardiac function
by: Taheri Shahram, et al.
Published: (2009-01-01)

Furosemide and spironolactone doses and hyponatremia in patients with heart failure
by: Ivan Velat, et al.
Published: (2020-08-01)

Spironolactone use is associated with lower risk of prostate cancer
by: K. Beckmann, et al.
Published: (2020-07-01)

Early Spironolactone Treatment Attenuates Heart Failure Development by Improving Myocardial Function and Reducing Fibrosis in Spontaneously Hypertensive Rats
by: Marcelo D.M. Cezar, et al.
Published: (2015-07-01)